Giannessi PG - Search Results

1

Tamoxifen and interferon-beta for the treatment of metastatic breast cancer.

Repetto L, Giannessi PG, Campora E, Pronzato P, Vigani A, Naso C, Spinelli I, Conte PF, Rosso R. Repetto L, et al. Among authors: giannessi pg. Breast Cancer Res Treat. 1996;39(2):235-8. doi: 10.1007/BF01806190. Breast Cancer Res Treat. 1996. PMID: 8872332 Clinical Trial.

2

In vivo cytokinetic effects of recombinant human growth hormone (rhGH) in patients with advanced breast carcinoma.

Baldini E, Giannessi PG, Gardin G, Alama A, Minuto F, Barreca A, Conte PF. Baldini E, et al. Among authors: giannessi pg. J Biol Regul Homeost Agents. 1994 Oct-Dec;8(4):113-6. J Biol Regul Homeost Agents. 1994. PMID: 7660852

3

Epidoxorubicin and lonidamine in refractory or recurrent epithelial ovarian cancer.

Gadducci A, Brunetti I, Muttini MP, Fanucchi A, Dargenio F, Giannessi PG, Conte PF. Gadducci A, et al. Among authors: giannessi pg. Eur J Cancer. 1994;30A(10):1432-5. doi: 10.1016/0959-8049(94)00231-s. Eur J Cancer. 1994. PMID: 7833097 Clinical Trial.

4

Delayed progression of bone metastases with pamidronate therapy in breast cancer patients: a randomized, multicenter phase III trial.

Conte PF, Giannessi PG, Latreille J, Mauriac L, Koliren L, Calabresi F, Ford JM. Conte PF, et al. Among authors: giannessi pg. Ann Oncol. 1994;5 Suppl 7:S41-4. Ann Oncol. 1994. PMID: 7873461 Clinical Trial.

5

Evaluation of taxol cardiotoxicity in metastatic breast cancer.

Biadi O, Mengozzi G, Gherarducci G, Strata G, Mariani M, Baldini F, Giannessi PG, Surbone A, Conte PF. Biadi O, et al. Among authors: giannessi pg. Ann N Y Acad Sci. 1993 Nov 30;698:403-5. doi: 10.1111/j.1749-6632.1993.tb17233.x. Ann N Y Acad Sci. 1993. PMID: 7904141 No abstract available.

6

Granulocyte-macrophage colony-stimulating factor (GM-CSF) allows acceleration and dose intensity increase of CEF chemotherapy: a randomised study in patients with advanced breast cancer.

Ardizzoni A, Venturini M, Sertoli MR, Giannessi PG, Brema F, Danova M, Testore F, Mariani GL, Pennucci MC, Queirolo P, et al. Ardizzoni A, et al. Among authors: giannessi pg. Br J Cancer. 1994 Feb;69(2):385-91. doi: 10.1038/bjc.1994.71. Br J Cancer. 1994. PMID: 8297739 Free PMC article. Clinical Trial.

7

Accelerated epirubicin-ifosfamide-dacarbazine regimen in patients with adult soft tissue sarcomas.

Michelotti A, Romanini A, Giannessi P, Bengala C, Conte P. Michelotti A, et al. Am J Clin Oncol. 1996 Feb;19(1):78-81. doi: 10.1097/00000421-199602000-00016. Am J Clin Oncol. 1996. PMID: 8554042 Clinical Trial.

8

Intraperitoneal infusion of recombinant human tumor necrosis factor and mitoxantrone in neoplastic ascites: a feasibility study.

Del Mastro L, Venturini M, Giannessi PG, Vigani A, Garrone O, Carnino F, Russo P, Galletti P, Rosso R, Conte PF. Del Mastro L, et al. Among authors: giannessi pg. Anticancer Res. 1995 Sep-Oct;15(5B):2207-12. Anticancer Res. 1995. PMID: 8572626

9

Activity and safety of epirubicin plus paclitaxel in advanced breast cancer.

Conte PF, Michelotti A, Baldini E, Tibaldi C, DaPrato M, Salvadori B, Giannessi PG, Gentile A, Biadi O, Mariani M. Conte PF, et al. Among authors: giannessi pg. Semin Oncol. 1996 Feb;23(1 Suppl 1):28-32. Semin Oncol. 1996. PMID: 8629033

10

Effects of primary chemotherapy on biological parameters of locally advanced breast cancer.

Collecchi P, Giannessi PG, Baldini E, Naccarato AG, Passoni A, Bevilacqua G, Conte PF. Collecchi P, et al. Among authors: giannessi pg. Ann N Y Acad Sci. 1996 Apr 30;784:419-26. doi: 10.1111/j.1749-6632.1996.tb16256.x. Ann N Y Acad Sci. 1996. PMID: 8651591 Clinical Trial. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

28 results

Search Page

Filters